Osteoarthritis Therapeutics Market

Osteoarthritis Therapeutics Market: Increase in the Prevalence of Osteoarthritis and Sports Injuries

Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. The osteoarthritis therapeutics market is estimated at $6.8 billion in 2019 and projected to reach $10.1 billion by 2024 at a CAGR of 8.1 percent from … Continue reading Osteoarthritis Therapeutics Market: Increase in the Prevalence of Osteoarthritis and Sports Injuries

Osteoarthritis Therapeutics Market

Osteoarthritis Therapeutics Market: Increasing Incidence of Sports Injuries

Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. The report says, is in part due to the rapid increase in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. The osteoarthritis … Continue reading Osteoarthritis Therapeutics Market: Increasing Incidence of Sports Injuries

Osteoarthritis Therapeutics Market

Osteoarthritis Therapeutics Market to reach USD 10.1 billion by 2024, at a CAGR of 8.1%

Industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. Global osteoarthritis therapeutics market is expected to grow from USD 6.8 billion in 2019 to reach USD 10.1 billion … Continue reading Osteoarthritis Therapeutics Market to reach USD 10.1 billion by 2024, at a CAGR of 8.1%

The Future of Osteoarthritis Therapeutics in Healthcare and Pharmaceuticals Industry

Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. The osteoarthritis therapeutics market is expected to grow from USD 6.8 billion in 2019 to reach USD 10.1 billion by 2024, at a CAGR of 8.1%. … Continue reading The Future of Osteoarthritis Therapeutics in Healthcare and Pharmaceuticals Industry